Impact of Clozapine Prescription on Inpatient Resource Utilization
The DOI matches its Crossref record.
Abstract
Although clozapine has been demonstrated to be clinically superior to typical neuroleptics in refractory schizophrenia, it is also more expensive. It had been hoped that the increased costs associated with its use would be offset by decreases in the utilization of other expensive resources, especially inpatient care. All patients who had clozapine initiated during an inpatient hospitalization within the VA for schizophrenia over a 4-year period (N = 1415) were matched with a comparison group (N = 2,830) on key service utilization variables and other possible confounding demographic and clinical variables using propensity scoring-an accepted statistical method, although still relatively little used in psychiatry. By using centralized VA databases, subsequent inpatient resource utilization for the 3 years after index discharge was examined. Veterans exposed to clozapine while inpatients recorded 33 (36%) more inpatient days in the subsequent 3 years after discharge than the comparison group (124 +/- 190 days vs. 91 +/- 181 days, p = .0002). When all patients exposed to clozapine were divided according to whether they had received 1 year of clozapine treatment after discharge, those that received less than 1 year's treatment recorded significantly more inpatient days than either those maintained on clozapine or controls. These results suggest that in actual practice clozapine treatment may cost substantially more than treatment with conventional neuroleptics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Principles for modeling propensity scores in medical research: a systematic literature review
Weitzen, S., Lapane, K. L., Toledano, A. Y., Hume, A. L., & Mor, V. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.969 · Cited by 344
The impact of clozapine on hospital use: a systematic review and meta-analysis
Land, R., Siskind, D., McArdle, P., Kisely, S., Winckel, K., & Hollingworth, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12700 · Cited by 141
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Pompili, M., Baldessarini, R., Forte, A., Erbuto, D., Serafini, G., Fiorillo, A., Amore, M., & Girardi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101700 · Cited by 78
“Suicide occurred at similarly low rates with both treatments, and was not altered during treatment with clozapine in this [38] or an earlier study [39].”
ResultPathological gamblers: Inpatients' versus outpatients' characteristics
Ladouceur, R., Sylvain, C., Sévigny, S., Poirier, L., Brisson, L., Dias, C., Dufour, C., & Pilote, P. (2006) · Journal of Gambling Studies · doi:10.1007/s10899-006-9022-8 · Cited by 27
Metadata
- Authors
- SERNYAK, M. J., ROSENHECK, R., DESAI, R., STOLAR, M., & RIPPER, G.
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 2001-11
- Volume
- 189
- Issue
- 11
- Pages
- 766-773
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W2323409798
- Cited by
- 36
- References
- 0
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Clozapine Prescription on Inpatient Resource Utilization. https://app.cochat.ai/papers/10.1097/00005053-200111000-00006
- The paper
- SERNYAK, M. J., ROSENHECK, R., DESAI, R., STOLAR, M., & RIPPER, G. (2001). Impact of Clozapine Prescription on Inpatient Resource Utilization. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-200111000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.